Core Insights - Ondas Holdings Inc. has invested $35 million in Performance Drone Works (PDW), enhancing PDW's operational capabilities and Ondas' position in the national security innovation ecosystem [2][3][9] Investment and Expansion - The $35 million investment will allow PDW to scale production of its C100 and AM-FPV platforms, increase engineering talent, and strengthen its supply chain with domestic, NDAA-compliant sourcing [3][9] - Ondas aims to identify collaboration opportunities with PDW to bolster homeland defense and support U.S. military operations [3] Financial Performance and Projections - Ondas anticipates at least $36 million in revenue for 2025, an increase from the previous estimate of $25 million, driven by strong performance in its OAS unit and recent acquisitions [5][9] - For 2026, Ondas targets at least $110 million in revenue, although quarterly results may vary based on order timing and rail-network development [5] Competitive Landscape - Draganfly Inc. has received a significant international military order for its Commander 3XL drones, enhancing its reputation in the defense sector [6] - Red Cat Holdings reported $9.6 million in revenue for Q3, marking a 646% year-over-year growth, driven by the U.S. Army's SRR Tranche 2 program [7] Market Performance - Ondas' shares have surged 587.3% over the past six months, contrasting with a 6.7% decline in the Communication - Network Software industry [10] - The forward 12-month Price/Sales ratio for Ondas is 31.3, significantly higher than the industry's multiple of 2 [11]

Core Viewpoint - Red Cat Holdings, Inc. (NASDAQ:RCAT) is recognized as one of the best small-cap defense stocks to buy, despite a recent price target reduction by Needham analyst Austin Bohlig from $17 to $12 [1][2]. Financial Performance - The company reported a significant quarterly revenue increase of 646% year-over-year, reaching $9.6 million in the third quarter of fiscal 2025 [5]. - The diluted loss per share remained unchanged at $0.16 compared to the previous year [5]. - For the fourth quarter, the company projects revenue between $20 million and $23 million, which would surpass its highest 12-month revenue if achieved [5]. Analyst Insights - Needham maintained a Buy rating for Red Cat Holdings, citing the Short Range Reconnaissance Tranche 2 (SRR T2) program as a key opportunity, despite anticipated delays until Q1 of 2026 [3]. - The analyst believes the nearly 48% decline in RCAT's shares year-to-date presents a buying opportunity, with positive prospects in the USV market and the SRR T2 program [4]. Market Context - The company's revised revenue guidance for the full year fell short of analysts' estimates, primarily due to delays in product launches and the impact of a government shutdown [2].

Company Performance - Red Cat Holdings, Inc. (RCAT) reported a Q3 '25 EPS loss of approximately -$0.16, missing expectations by $0.07 [1] - Revenue for the same period was $9.65 million, significantly below the consensus estimate of $14.12 million [1] - The market reaction to these results was negative, leading to a decline in share prices [1] Analyst Background - The analyst has a Master's degree in Cell Biology and extensive experience in drug discovery, focusing on biotechnology investments [1] - The analyst's approach combines scientific expertise with financial analysis to identify promising biotechnology companies [1] - The focus is on evaluating drug candidates, competitive landscapes, clinical trial designs, and market opportunities while considering financial fundamentals [1]

Core Insights - Red Cat Holdings, Inc. (RCAT) reported a Q3 2025 EPS loss of approximately -$0.16, which was $0.07 below expectations [1] - The company's revenue for the quarter was $9.65 million, significantly lower than the consensus estimate of $14.12 million [1] - The market reacted negatively to these results, leading to a decline in share prices [1]

Core Insights - U.S. stock futures are lower, with Dow futures down approximately 100 points [1] - Red Cat Holdings Inc reported disappointing third-quarter results, leading to a significant drop in its stock price [2] Company Performance - Red Cat Holdings Inc's third-quarter revenue was $9.65 million, falling short of analyst expectations of $16.68 million [2] - The company reported a loss of 16 cents per share, which was worse than the anticipated loss of 10 cents per share [2] - Following the earnings report, Red Cat's shares fell by 15.1% to $6.57 in pre-market trading [2] Other Companies' Performance - TSS Inc experienced a 40.2% decline to $9.10 after reporting a year-over-year decrease in third-quarter results [4] - StubHub Holdings Inc's shares dropped 18.8% to $15.28 due to worse-than-expected third-quarter EPS results [4] - WhiteFiber Inc's stock fell 13.4% to $17.21 after reporting disappointing third-quarter financial results [4] - Anavex Life Sciences Corp. saw a decline of 12.3% to $4.99, following an 18% drop the previous day [4] - Verastem Inc's shares dipped 9.4% to $7.35 after announcing a $90 million public offering [4] - POET Technologies Inc fell 8.5% to $4.30 due to weak quarterly results [4] - Solaris Energy Infrastructure Inc declined 5.8% to $42.32 in pre-market trading [4]

Core Insights - U.S. stock futures are lower, with Dow futures down approximately 100 points [1] - Red Cat Holdings Inc reported disappointing third-quarter results, leading to a significant drop in its stock price [2] Company Performance - Red Cat Holdings Inc's third-quarter revenue was $9.65 million, falling short of analyst expectations of $16.68 million [2] - The company reported a loss of 16 cents per share, which was worse than the anticipated loss of 10 cents per share [2] - Red Cat's shares fell by 15.1%, reaching $6.57 in pre-market trading [2] Other Companies' Performance - TSS Inc experienced a 40.2% decline, with shares dropping to $9.10 after reporting a year-over-year decrease in financial results [4] - StubHub Holdings Inc's shares fell 18.8% to $15.28 following disappointing third-quarter EPS results [4] - WhiteFiber Inc's stock decreased by 13.4% to $17.21 after reporting worse-than-expected financial results [4] - Anavex Life Sciences Corp. saw a decline of 12.3%, with shares at $4.99 after an 18% drop the previous day [4] - Verastem Inc's shares dipped 9.4% to $7.35 due to the announcement of a $90 million public offering [4] - POET Technologies Inc fell 8.5% to $4.30 following weak quarterly results [4] - Solaris Energy Infrastructure Inc declined 5.8% to $42.32 in pre-market trading [4]

Core Viewpoint - Red Cat Holdings, Inc. (RCAT) is conducting a conference call to discuss its financial results for the eight-month stub period ending December 31, 2024, and to provide a corporate update [1][2]. Company Overview - The conference call features Jeff Thompson, who serves as the Chief Executive Officer and Interim Chief Financial Officer of Red Cat Holdings [2][5]. - The call is being broadcast live over the Internet and will be available for replay approximately one hour after the call concludes [2]. Financial Performance - Management will present forward-looking statements regarding Red Cat's expectations for future performance and operational results [3].

Core Viewpoint - Red Cat Holdings, Inc. is conducting a conference call to discuss its financial results for the eight-month stub period ending December 31, 2024, and to provide a corporate update [1]. Group 1: Company Overview - The conference call features Jeff Thompson, who serves as the Chairman of the Board, CEO, and President of Red Cat Holdings [1]. - The call is being broadcast live over the Internet and will be recorded for playback, with a replay available approximately one hour after the call [2]. Group 2: Financial Performance - The call will include forward-looking statements regarding Red Cat's expectations for future performance and operational results [3]. - Management will address various factors that may influence actual results, highlighting the importance of understanding the associated risks [4].

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential opportunities for traders before the market opens [1] Premarket Gainers - Cidara Therapeutics, Inc. (CDTX) is up 91% at $203.18 - Binah Capital Group, Inc. (BCG) is up 45% at $2.07 - Invivyd, Inc. (IVVD) is up 42% at $2.52 - Omeros Corporation (OMER) is up 15% at $7.25 - The Oncology Institute, Inc. (TOI) is up 12% at $3.47 - AlphaVest Acquisition Corp (ATMV) is up 11% at $7.99 - ARB IOT Group Limited (ARBB) is up 7% at $7.31 - Hyperion DeFi, Inc. (HYPD) is up 6% at $5.27 - TruGolf Holdings, Inc. (TRUG) is up 6% at $2.02 - Boqii Holding Limited (BQ) is up 5% at $2.24 [3] Premarket Losers - TSS, Inc. (TSSI) is down 40% at $9.12 - StubHub Holdings, Inc. (STUB) is down 20% at $15.02 - ESS Tech, Inc. (GWH) is down 20% at $3.38 - Red Cat Holdings, Inc. (RCAT) is down 17% at $6.38 - WhiteFiber, Inc. (WYFI) is down 15% at $16.81 - New Era Energy & Digital, Inc. (NUAI) is down 13% at $3.66 - NET Power Inc. (NPWR) is down 11% at $2.62 - Korro Bio, Inc. (KRRO) is down 9% at $5.90 - Anavex Life Sciences Corp. (AVXL) is down 8% at $5.20 - Interactive Strength Inc. (TRNR) is down 5% at $2.47 [4]

Group 1: RLX Technology Inc - RLX Technology Inc reported quarterly earnings of 3 cents per share on sales of $158.600 million [1] - Shares of RLX Technology rose 6% to $2.47 in pre-market trading following the earnings report [1] Group 2: Other Stocks in Pre-Market Trading - Cidara Therapeutics, Inc. surged 92% to $203.50 after a Schedule 13D Amendment revealed beneficial ownership of 3.37 million shares [4] - Binah Capital Group, Inc. gained 52.2% to $2.17 after posting stronger-than-expected third-quarter results [4] - Expion360 Inc. rose 42.4% to $1.81 following its third-quarter results [4] - Aspire Biopharma Holdings, Inc. surged 31.2% to $0.1380 in pre-market trading [4] - Invivyd, Inc. gained 28.8% to $2.28 after reporting better-than-expected third-quarter financial results [4] - Milestone Scientific Inc. surged 26.3% to $0.4801 after reporting better-than-expected third-quarter sales [4] - Lazydays Holdings, Inc. gained 23.3% to $1.85 after a previous surge [4] - Omeros Corp gained 12.5% to $7.08 following a narrower-than-expected quarterly loss [4] - Nouveau Monde Graphite Inc rose 10% to $3.25 after a decline the previous day [4] Group 3: Declining Stocks in Pre-Market Trading - TSS Inc tumbled 40.2% to $9.10 after reporting a year-over-year decrease in third-quarter results [4] - enVVeno Medical Corp declined 35.8% to $0.42 after an unfavorable FDA appeal decision [4] - Nuvve Holding Corp fell 29.3% to $0.34 after announcing third-quarter results [4] - ESS Tech Inc shares dipped 24.2% to $3.22 after reporting weak quarterly sales [4] - Direct Digital Holdings Inc fell 18.8% to $0.23 after a significant gain the previous day [4] - StubHub Holdings Inc fell 18.8% to $15.28 after worse-than-expected third-quarter EPS results [4] - Mangoceuticals Inc dipped 17.7% to $0.98 after a decline the previous day [4] - Red Cat Holdings Inc dipped 15.1% to $6.57 after worse-than-expected financial results and a lowered FY25 sales guidance [4] - WhiteFiber Inc fell 13.4% to $17.21 after reporting worse-than-expected financial results [4] - Sobr Safe Inc fell 12.4% to $2.21 after a decline the previous day [4]